Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Monte Rosa Therapeutics, Inc. | Chief Business & Legal Officer | Stock Option (Right to Buy) | 40K | Jun 3, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
GLUE | Monte Rosa Therapeutics, Inc. | Jun 3, 2024 | 1 | $0 | 4 | Jun 5, 2024 | Chief Business & Legal Officer |
GLUE | Monte Rosa Therapeutics, Inc. | Jan 2, 2024 | 1 | $0 | 4 | Jan 4, 2024 | General Counsel |
GLUE | Monte Rosa Therapeutics, Inc. | Jan 3, 2023 | 1 | $0 | 4 | Jan 4, 2023 | General Counsel |
GLUE | Monte Rosa Therapeutics, Inc. | Mar 1, 2022 | 1 | $0 | 4 | Mar 2, 2022 | General Counsel |
GLUE | Monte Rosa Therapeutics, Inc. | Mar 1, 2022 | 0 | $0 | 3 | Mar 2, 2022 | General Counsel |